Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GARRIDO LESTACHE Y CABRERA ANT
Original Assignee
GARRIDO LESTACHE Y CABRERA ANT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GARRIDO LESTACHE Y CABRERA ANTfiledCriticalGARRIDO LESTACHE Y CABRERA ANT
Priority to ES8903701ApriorityCriticalpatent/ES2018413A6/es
Publication of ES2018413A6publicationCriticalpatent/ES2018413A6/es
EL PROCEDIMIENTO SE REFIERE A UAN PREPARACION ANTICARIOGENA ORAL SOLIDA QUE SE OBTIENE PARTIENDO DE UNA GOMA BASE, AZUCAR, GLUCOSA, AROMA, GLICERINA, Y ACIDULANTES MEZCLADOS EN UNA PROPORCION ADECUADA, CALENTANDOSE EN PRIMER LUGAR LA GOMA BASE Y POSTERIORMENTE MEZCLANDOSE EL RESTO DE LOS ELEMENTOS HASTA OBTENER UNA HOMOGENEIDAD Y CALENTANDO ESTA MASA A 40GC. SE INCORPORA LA GOMA BASE, EXTRUSIONANDOSE Y LAMINANDOSE POSTERIORMENTE Y DEJANDO LA MASA OBTENIDA EN REPOSO DURANTE UN PERIODO DE 12 A 24 HORAS.
ES8903701A1989-11-021989-11-02Procedimiento para la preparacion de una composicion anticariogena oral solida.
Expired - LifetimeES2018413A6
(es)
Process to prepare a two-phase pharmaceutical composition with niphedypine <dimethylic acid esther 1,4-di-hydro-2,6-dimethyl- 4-(2 nitrophenyl)-3,5-pyridine-dicarboxilic> in non-crystallin e and crystalline forms
Process for producing pharmaceutical compositions comprising toremifen and its metabolites, suitable for ceasing the simultaneous resistance of cancer cells to several cytotoxic active ingredients